Prostate cancer staging using imaging

BJU International, Supplement

Volumn 86, Issue 1, 2000, Pages 123-134

  Engelbrecht, M R W ^a   Barentsz, J O ^a   Jager, G J ^a   Van Der Graaf, M ^a   Heerschap, A ^a   Sedelaar, J P M ^a   Aarnink, R G ^a   De La Rosette, J J M C H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER STAGING; FUTUROLOGY; HUMAN; IMAGING; MALE; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; UNITED STATES;

HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM STAGING; PROSTATIC NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0033947806     PISSN: 14655101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2000.00592.x     Document Type: Review

References (84)

1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics 1998. CA Cancer J Clin 1998; 48: 6-29
2. Imperial Cancer Research Fund. Cancer Statistics 1995. (http:www.icnetuk/research/factsheet/canstatshtml)
3. American Cancer Society. Cancer Facts and Figures 1998. (http.//www.cancer.org.statisticscff98/graphicaldatahtml)
4. Catalona WJ. Surgical management of prostate cancer: contemporary results with anatomic radical prostatectomy. Cancer 1995; 75: 1903-8
5. Donovan JL, Frankel SJ, Faulkner A, Selley S, Gillatt S, Hamdy FC. Dilemmas in treating early prostate cancer: the evidence and a questionnaire survey of consultant urologists in the United Kingdom. Br Med J 1999; 318: 299-300
6. Jewett HJ. Significance of the palpable prostatic nodule. JAMA 1956: 160: 838-9
7. Smith DS, Catalona WJ. Interexaminer variability of digital rectal examination in detecting prostate cancer. Urology 1995; 45: 70-4
8. Voges GE, McNeal JE, Redwine E, Freiha FS, Stamey TA. Morphologic analysis of surgical margins with positive findings in prostatectomy for adenocarcinoma of the prostate. Cancer 1992; 69: 520-6
9. Epstein JI, Pizov G, Walsh PC. Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer 1993; 71: 3582-93
10. Partin AW, Yoo J, Ballentine Carter JY et al. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized proslate cancer. J Urol 1993; 150: 110-5
11. Kleer E, Oesterling JE. PSA and staging of localized prostate cancer. Urol Clin North Am 1993; 20: 695-704
12. Watanabe H. History and applications of transrectal sonography of the prostate. Urol Clin North Am 1989; 16: 617-22
13. Giesen RJB, Huynen AL, Aarnink RG et al. Computer analysis of transrectal ultrasound images of the prostate for the detection of carcinoma: a prospective study in radical prostatectomy specimens. J Urol 1995; 154: 1397-400
14. Chodak GW, Wald V, Parmer E, Watanahe H, Ohe H, Saitoh M. Comparison of digital examination and transrectal ultrasonography for the diagnosis of prostatic cancer. J Urol 1986; 135: 951-4
15. Lee F, Torp-Pedersen S, Littrup PJ et al. Hypoechoic lesions of the prostate: clinical relevance of tumor size, digital rectal examination, and prostate specific antigen. Radiology 1989; 170: 23-7
16. Lee F, Torp-Pedersen ST, McLeary RD. Diagnosis of prostate cancer by transrectal ultrasound. Urol Clin North Am 1989; 16: 663-73
17. Lee F, Torp-Pedersen ST, Siders DB, Littrup PJ, McLeary RD. Transrectal ultrasound in the diagnosis and staging of prostatic carcinoma. Radiology 1989; 170: 609-15
18. Terris MK, Freiha FS, McNeal JE, Stamey TA. Efficacy of transrectal ultrasound for identification of clinically undetected prostate cancer. J Urol 1991; 146: 78-83
19. Oyen RH, Van Poppel HP, Van de Voorde WA, Knapen W, Ameye F. The significance of focal hypoechoic lesions in the peripheral zone of the prostate. J Belg Rad 1995; 78: 356-8
20. Sibley RI, Sibley AF. Correlation of digital rectal examination, prostate specific antigen, and transrectal ultrasound in prostate carcinoma in African Americans. J Nat Med Ass 1997; 89: 318-23
21. Ellis WJ, Brawer MK. The significance of isoechoic prostatic carcinoma. J Urol 1994; 152: 2304-7
22. Aarnink RG, de la Rosette J, Witjes JA, Debruyne FM, Wijkstra H. [Diagnosis of prostate cancer in urination disorders in urological practice: current status and future developments] Diagnostiek van prostaatkanker bij mictieklachten in de urologische praktijk: huidige stand van zaken en toekomstige ontwikkelingen. Tijdschr Gerontol Geriatr 1997; 28: 264-71
23. Rifkin MD, Zerhouni EA, Gatsonis CA et al. Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trial. N Engl J Med 1990; 323: 621-6
24. Presti JC, Hricak H, Narayan P, Shinohara K, White S, Carroll PR. Local staging of prostatic carcinoma: comparison of transrectal sonography and endorectal MR imaging. Am J Roentgenol 1996; 166: 103-8
25. Ruijter ETG, van de Kaa CA, Schalken JA, Debruyne FM, Ruiter DJ. Histological grade heterogeneity in multifocal prostate cancer. Biological and clinical implications. J Pathol 1996; 180: 295-9
26. Beerlage HP, de Reijke TM, de la Rosette J. Considerations regarding prostate biopsies. European Urol 1998; 34: 303-12
27. Folkman J. The role of angiogcncsis in tumor growth. Sem Cancer Biol 1992; 3: 65-71
28. Folkman J. What is the evidence that tumors are angiogenesis dependent. J Natl Cancer Inst 1990; 82: 4-6
29. Bigler S, Deerings RE, Brawer MK. Comparison of microscopic vascularity in benign and malignant prostate tissue. Hum Pathol 1993; 24: 220-6
30. Bostwick DG. Practical clinical application of predictive factors in prostate cancer. Anal Quant Cytol Histol 1990; 20: 323-42
31. Bostwick DG, Iczkowski KA. Microvessel density in prostate cancer: prognostic and therapeutic utility. Semin Urol Oncol 1998; 16: 118-23
32. Rifkin MD, Sudakoff GS, Alexander AA. Prostate: techniques, results, and potential applications of color Doppler US scanning. Radiology 1993; 186: 509-13
33. Kelly IMG, Lees WR. Prostate cancer and the role of color Doppler US. Radiology 1993; 189: 153-6
34. Newman JS, Bree RL, Rubin JM. Prostate Cancer: Diagnosis with color doppler sonography with histologic correlation of each biopsy site. Radiology 1995; 195: 86-90
35. Patel U, Rickards D. The diagnostic value of colour Doppler flow in the peripheral zone of the prostate with histological correlation. Br J Urol 1994; 74: 590-5
36. Cornud F, Belin X, Piron D et al. Color Doppler-guided prostate biopsies in 591 patients with an elevated serum PSA level: impact on Gleason score for nonpalpable lesions. Urology 1997; 49: 709-15
37. Ismail M, Gomella LG, Alexander AA. Color Doppler sonography of the prostate. Tech Urol 1997; 3: 140-6
38. Giesen RJ, Huynen AL, de la Rosette JMCH, Aarnink RG, Debruyne FM, Wijkstra H. Ultrasonic computer imaging of the prostate; correlation between longitudinal and transverse texture descriptions. Eur J Ultrasound 1998; 2: 145-9
39. Huynen AL, Giesen RJ, de la Rosette J, Aarnink RG, Debruyne FM, Wijkstra H. Analysis of ultrasonographic prostate images for the detection of prostatic carcinoma: the automated urologic diagnostic expert system. Ultrasound Med Biol 1994; 20: 1-10
40. Cosgrove D. Ultrasound contrast enhancement of tumours. Clin Radiol 1996; 51: 44-9
41. Spencer KT, Bednarz J, Rafter PG, Korcarz C, Lang RM. Use of harmonic imaging without echocardiographic contrast to improve two-dimensional image quality. Am J Cardiol 1998; 82: 794-9
42. Maresca G, Summaria V, Colagrande C, Manfredi R, Calliada F. New prospects for ultrasound contrast agents. Eur J Radiol 1998; 27: S171-8
43. Ragde H, Kenny GM, Murphy GP, Landin K. Transrectal ultrasound microbubble contrast angiography of the prostate. Prostate 1997; 32: 279-83
44. Aarnink RG, Beerlage HP, de la Rosette JJMCH, Debruyne FMJ, Wijkstra H. Transrectal ultrasound of the prostate: innovations and future applications. J Urol 1998; 159: 1568-79
45. Jager GJ, Barentsz JO. Prostate cancer. In: Husband J, ed. Oncology Imaging. Chapter 15. Oxford, Isis Medical Media, 1990: 239-57
46. Langlotz CP. Benefits and costs of MR imaging of prostate cancer. MRI Clinics North Am 1996; 4: 533-45
47. White S, Hricak H, Forstner R et al. Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. Radiology 1995; 195: 385-90
48. Hricak H, White S, Vigneron DB et al. Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal-pelvic phased-array coils. Radiology 1994; 193: 703-9
49. Bartolozzi C, Menchi I, Lencioni R et al. Local staging of prostate carcinoma with endorectal coil MRL correlation with whole mount radical prostatectomy specimens. Eur Radiol 1996; 6: 339-45
50. Langlotz CP, Schnall MD, Malkowicz SB, Schwartz JS. Cost-effectiveness of endorectal magnetic resonance imaging for the staging of prostate cancer. Acad Radiol 1996; 3: S24-7
51. Schiebler ML, Schnall MD, Pollack HM et al. Current role of MR imaging in the staging of adenocarcinoma of the prostate. Radiology 1993; 189: 339-52
52. Chernoff DM, Hricak H. The Male Pelvis: Prostate and Seminal vesicles. In: Higgins CB, Hricak H, eds. Magnetic Resonance Imaging of the Body. Chapt 33, 3rd edn. New York: Lippincott-Raven Press 1997: 875-900
53. Ramchandani P, Schnall MD, LiVolsi VA, Tomaszewski JE, Pollack HM. Senile amyloidosis of the seminal vesicles mimicking metastatic spread of prostatic carcinoma on MR images. Am J Roentgenol 1993; 161: 99-100
54. Jager G, Ruijter E, de la Rosette J, van de Kaa CA. Amyloidosis of the seminal vesicles simulating tumor invasion of prostatic carcinoma on endorectal MR images. Eur J Radiol 1997; 7: 552-4
55. Langlotz CP, Schnall MD, Pollack H. Staging of prostatic cancer: accuracy of MR imaging. Radiology 1995; 194: 645-6
56. Jager GJ, Thornbury J, Barentsz JO et al. MR staging in prostate cancer (pc): Influence on patient outcome and effective analysis. RSNA 1998: 181
57. Rørvik J, Halvorsen OJ, Albrektsen G, Ersland L, Daehlin L, Haukaas S. MRI with an endorectal coil for staging of clinically localised prostate cancer prior to radical prostatectomy. Eur Radiol 1999; 9: 29-34
58. Schnall MD, Imai Y, Tomaszewski JE, Pollack HM, Lenkinski RE, Kressel HY. Prostate cancer: local staging with endorectal surface coil MR imaging. Radiology 1991; 178: 797-802
59. Chelsky MJ, Schnall MD, Seidmon EJ, Pollack HM. Use of endorectal surface coil magnetic resonance imaging for local staging of prostate cancer. J Urol 1993; 150: 391-5
60. Outwater E, Petersen RO, Siegelman ES, Gomella LG, Chernesky CE, Mitchell DG. Prostate carcinoma: assessment of diagnostic criteria for capsular penetration on endorectal coil MR images. Radiology 1994; 193: 333-9
61. Kedar RP, Kier R, Viner N et al. Proceedings of the International Society of Magnetic Resonance in Medicine 1999: poster 1106
62. Jain RK. Barriers to drug delivery in solid tumors. Sci Am 1994; 270: 42-9
63. Delorme S, Knopp MV. Non-invasive vascular imaging: assessing tumour vascularity. Eur J Radiol 1998; 4: 517-27
64. Jager G, Ruijter E, van de Kaa C et al. Dynamic Turbo-flash subtraction technique for contrast-enhanced MR images of the prostate: correlation with histopathology. Radiology 1997; 203: 645-52
65. Brown G, Macvicar DA, Ayton V, Husband JE. The role of intravenous contrast enhancement in magnetic resonance imaging of prostatic carcinoma. Clin Radiol 1995; 50: 601-6
66. Preziosi P, Di Giambattista G, Di Renzi P et al. Endorectal-coil Magnetic Resonance Imaging with dynamic subtraction technique in prostate cancer: evaluation of tumoral tissue behaviour with the time/signal intensity curve analysis. Abstract. RSNA 1998: 259
67. 3) spatial resolution. Radiology 1997; 198: 795-805
68. Heerschap A, Jager GJ, van der Graaf M et al. In vivo proton MR spectroscopy reveals altered metabolite content in malignant prostate tissue. Anticancer Res 1997; 17: 1455-60
69. Kurhanewicz J, Males R, Sokolov D et al. Combined Endorectal/phased-array MR imaging and 3-D H-MR Spectroscopic imaging for improved diagnosis of extracapsular extension in prostate cancer. [Abstract] Proceedings of the International Society of Magnetic Resonance in Medicine, 1998
70. Vigneron DB, Males R, Noworolski S et al. 3D MRSI of prostate cancer: correlations with histologic grade. Proceedings of the International Society of Magnetic Resonance in Medicine, 1998
71. Males R, Vigneron DB, Nelson AD et al. Addition of MR spectroscopic imaging to MRI significantly improves detection and localization of prostate cancer. Proceedings of the International Society of Magnetic Resonance in Medicine, 1998
72. Davis GL. Sensitivity of frozen section examination of pelvic lymph node for metastatic prostate carcinoma. Cancer 1995; 76: 661-8
73. Scheidler J, Hricak H, Yu KK, Subak L, Segal MR. Radiological Evaluation of lymph node metastases in patients with cervical cancer. JAMA 1997; 278: 1096-10
74. Jager GJ, Barentsz JO, Oosterhof G, Witjes JA, Ruijs SHJ. Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional T1-weighted magnetization-prepared rapid gradient-echo sequence. Am J Roentgenol 1996; 167: 1503-7
75. Barentsz JO. MR intervention in the pelvis: an overview and first experiences in MR-guided biopsy in nodal metastases in urinary bladder cancer. Abdom Imaging 1997; 22: 524-30
76. Vinnicombe SJ, Norman AR, Nicolson V, Husband JE. Normal pelvic lymph nodes: evaluation by CT scanning after bipedal lymphangiography. Radiology 1995; 194: 349-55
77. Oyen RH, Van Poppel HP, Ameye FE, Van de Voorde WA, Baert AL, Baert LV. Lymph node staging of localized prostatic carcinoma with CT and CT-guided fine-needle aspiration biopsy: prospective study of 285 patients. Radiology 1994; 190: 315-22
78. Wolf JS, Cher M, dalla'Era M, Presti JC, Hricak H, Carroll PR. The use and accuracy of cross-sectional imaging and fine needle aspiration cytology for detection of pelvic lymph node metastases before radical prostatectomy. J Urol 1995; 153: 993-9
79. Haukaas S, Rørvik J, Halvorsen OJ, Foellings M. When is bone scintigraphy necessary in the assessment of newly diagnosed, untreated prostate cancer. Br J Urol 1997; 79: 770-6
80. Algra PR, Bloem JL, Tissing H, Falke THM, Arndt JW, Verboom LJ. Detection of vertebral metastases: comparison between MR imaging and bone scintigraphy. Radiographics 1991; 11: 219-32
81. Weissleder R, Elizondo G, Wittenberg J, Lee AS, Josephson L, Brady TJ. Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymphnodes with MR imaging. Radiology 1990; 175: 494-8
82. Fngelbrecht MR, Taupitz M, Hamm B et al. The value of MR-lymphangiography in staging urological tumours. [Abstract]. European Congress of Radiology 1999: 1568
83. McNeal JE. Cancer and site of origin of adenocarcinoma of the prostate: relationship to local and distant spread. Hum Pathol 1992; 23: 258-66
84. Yu KK, Hricak H, Alagappan R, Chernoff DM, Bacchetti P, Zaloudek CJ. Detection of extracapsular extension of prostate carcinoma with endorectal and phased-array coil MR imaging: multivariate feature analysis. Radiology 1997; 202: 697-702